The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

被引:137
作者
Gourlet, P [1 ]
Vertongen, P [1 ]
Vandermeers, A [1 ]
VandermeersPiret, MC [1 ]
Rathe, J [1 ]
DeNeef, P [1 ]
Waelbroeck, M [1 ]
Robberecht, P [1 ]
机构
[1] FREE UNIV BRUSSELS, SCH MED, DEPT BIOCHEM & NUTR, B-1070 BRUSSELS, BELGIUM
关键词
RO; 25-1553; selectivity; VIP2 receptor agonist; ADENYLATE-CYCLASE; FUNCTIONAL-CHARACTERIZATION; SUP-T1; LYMPHOBLASTS; PEPTIDE AGONIST; IN-VITRO; PACAP; HELODERMIN; CLONING; CELLS; EXPRESSION;
D O I
10.1016/S0196-9781(96)00322-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RO 25-1553 is a synthetic VIP analogue that induced a longlasting relaxation of tracheal and bronchial smooth muscles as well as a reduction of edema and eosinophilic mobilization during pulmonary anaphylaxis. In the present study, we tested in vitro the capacity of RO 25-1553 to occupy the different VIP/PACAP receptor subclasses and to stimulate adenylate cyclase activity. The cellular models tested expressed one single receptor subtype: Chinese hamster ovary (CHO) cells transfected with the rat recombinant PACAP I, rat VIP1, and human VIP2 receptors; SUP T1 cells expressing the human VIP2 and HCT 15 and LoVo cells expressing the human VIP1 receptor. RO 25-1553 was threefold more potent than VIP on the human VIP2 receptor, 100- and 600-fold less potent than VIP on the rat and human VLP1 receptors, respectively, and 10-fold less potent than VIP and 3000-fold less potent than PACAP on the PACAP I receptor. RO 25-1553 was a full agonist on the VIP2, the PACAP I, and the rat recombinant VIP1 receptor but a partial agonist only on the human VIP1 receptor. Thus, RO 25-1553 is a highly selective agonist ligand for the VIP2 receptor subclass. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 30 条
[1]   PROPERTIES OF VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS AND BETA-ADRENOCEPTORS IN THE MURINE RADIATION LEUKEMIA-VIRUS-INDUCED LYMPHOMA CELL-LINE BL/VL3 [J].
ABELLO, J ;
DAMIEN, C ;
DENEEF, P ;
TASTENOY, M ;
HOOGHE, R ;
ROBBERECHT, P ;
CHRISTOPHE, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 183 (02) :263-267
[2]  
BOLIN DR, 1992, BIOMED RES-TOKYO, V13, P25
[3]  
BOLIN DR, 1989, PEPTIDES CHEM BIOL, P208
[4]   PRESENCE OF HIGHLY SELECTIVE RECEPTORS FOR PACAP (PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE) IN MEMBRANES FROM THE RAT PANCREATIC ACINAR CELL-LINE AR-4-2J [J].
BUSCAIL, L ;
GOURLET, P ;
CAUVIN, A ;
DENEEF, P ;
GOSSEN, D ;
ARIMURA, A ;
MIYATA, A ;
COY, DH ;
ROBBERECHT, P ;
CHRISTOPHE, J .
FEBS LETTERS, 1990, 262 (01) :77-81
[5]   TYPE-I RECEPTORS FOR PACAP (A NEUROPEPTIDE EVEN MORE IMPORTANT THAN VIP) [J].
CHRISTOPHE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (02) :183-199
[6]   PROPERTIES OF THE VIP-PACAP TYPE-II RECEPTOR STABLY EXPRESSED IN CHO CELLS [J].
CICCARELLI, E ;
VILARDAGA, JP ;
DENEEF, P ;
DIPAOLO, E ;
WAELBROECK, M ;
BOLLEN, A ;
ROBBERECHT, P .
REGULATORY PEPTIDES, 1994, 54 (2-3) :397-407
[7]   PHARMACOLOGICAL PROPERTIES OF 2 RECOMBINANT SPLICE VARIANTS OF THE PACAP TYPE-I RECEPTOR, TRANSFECTED AND STABLY EXPRESSED IN CHO CELLS [J].
CICCARELLI, E ;
SVOBODA, M ;
DENEEF, P ;
DIPAOLO, E ;
BOLLEN, A ;
DUBEAUX, C ;
VILARDAGA, JP ;
WAELBROECK, M ;
ROBBERECHT, P .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 288 (03) :259-267
[8]   HUMAN INTESTINAL VIP RECEPTOR - CLONING AND FUNCTIONAL EXPRESSION OF 2 CDNA-ENCODING PROTEINS WITH DIFFERENT N-TERMINAL DOMAINS [J].
COUVINEAU, A ;
ROUYERFESSARD, C ;
DARMOUL, D ;
MAORET, JJ ;
CARRERO, I ;
OGIERDENIS, E ;
LABURTHE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (02) :769-776
[9]  
COUVINEAU A, 1994, VASOACTIVE INTESTINA, P129
[10]   ADENYLATE-CYCLASE ACTIVATION BY VIP-HELODERMIN AND HISTAMINE H-2 RECEPTORS IN HUMAN THP-1 MONOCYTES MACROPHAGES - A POSSIBLE ROLE IN THE REGULATION OF SUPEROXIDE ANIONS PRODUCTION [J].
GESPACH, C ;
CHEDEVILLE, A ;
HURBAINKOSMATH, I ;
HOUSSET, B ;
DERENNE, JP ;
ABITA, JP .
REGULATORY PEPTIDES, 1989, 26 (02) :158-158